Alert detail
FDA Approval: RANLUSPEC (RANIBIZUMAB-HKDZ) — Type 2 - New Active Ingredient
Policy ID: FDA-BLA761480Specialty: OphthalmologyAdded: 6/6/2026Effective: 2026-06-02federal register
Full alert analysis requires a subscription
Subscribe to access the complete alert summary, AI-generated action recommendations, source document links, LCD revision comparisons, and related alerts.